View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Novak Christy Lynn
(Last) (First) (Middle)
C/O NOV INC.
7909 PARKWOOD CIRCLE DRIVE
(Street)
HOUSTON TX 77036
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2021 		3. Issuer Name and Ticker or Trading Symbol
NOV Inc. [ NOV ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Corp. Controller, CAO
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 14,708 D
Common Stock 1,665(1) D
Common Stock 4,560(2) D
Common Stock 9,225(3) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) (4) 02/22/2022 Common Stock 2,490 77.99 D
Non-Qualified Stock Option (right to buy) (5) 02/16/2023 Common Stock 2,750 63.93 D
Non-Qualified Stock Option (right to buy) (6) 02/26/2024 Common Stock 4,813 69 D
Non-Qualified Stock Option (right to buy) (7) 02/26/2025 Common Stock 11,900 54.74 D
Non-Qualified Stock Option (right to buy) (8) 02/23/2027 Common Stock 6,360 38.86 D
Non-Qualified Stock Option (right to buy) (9) 02/25/2026 Common Stock 17,940 34.32 D
Non-Qualified Stock Option (right to buy) (10) 02/29/2028 Common Stock 7,114 35.09 D
Non-Qualified Stock Option (right to buy) (11) 02/28/2029 Common Stock 6,758 28.72 D
Non-Qualified Stock Option (right to buy) (12) 02/26/2030 Common Stock 7,912 20.23 D
Non-Qualified Stock Option (right to buy) (13) 02/23/2031 Common Stock 8,106 15 D
Explanation of Responses:
1. Represents the remaining unvested portion of time-based restricted stock granted on 02/27/2019 pursuant to the Issuer's 2018 Long-Term Incentive Plan, which began vesting in three equal annual installments on the first anniversary of the date of the grant.
2. Represents the remaining unvested portion of time-based restricted stock granted on 02/25/2020 pursuant to the Issuer's 2018 Long-Term Incentive Plan, which began vesting in three equal annual installments on the first anniversary of the date of the grant.
3. Represents a time-based restricted stock award granted on 02/22/2021 pursuant to the Issuer's 2018 Long-Term Incentive Plan, which will vest in three equal annual installments commencing on the first anniversary of the date of the grant.
4. This option is exercisable in three equal annual installments beginning on 02/21/2013.
5. This option is exercisable in three equal annual installments beginning on 02/15/2014.
6. This option is exercisable in three equal annual installments beginning on 02/25/2015.
7. This option is exercisable in three equal annual installments beginning on 02/25/2016.
8. This option is exercisable in three equal annual installments beginning on 02/22/2018.
9. This option is exercisable in three equal annual installments beginning on 02/24/2017 for the first installment, 12/20/2017 for the second installment and 02/24/2019 for the third installment.
10. This option is exercisable in three equal annual installments beginning on 02/28/2019.
11. This option is exercisable in three equal annual installments beginning on 02/27/2020.
12. This option is exercisable in three equal annual installments beginning on 02/25/2021.
13. This option is exercisable in three equal annual installments beginning on 02/22/2022.
Remarks:
See Exhibit 24.1 - Power of Attorney
/s/ Brigitte Hunt, Attorney-in-Fact For: Christy L. Novak 11/08/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                               POWER OF ATTORNEY

        The undersigned constitutes and appoints John Niedzwiecki, J. Eric
Johnson, Ben Smolij, Brigitte Hunt, and Anna Gryska, and each of them
individually, as the undersigned's true and lawful attorneys-in-fact and agents
for the undersigned and in the undersigned's name, place and stead, to:

        1.   prepare, sign, and submit to the Securities and Exchange Commission
            (the "SEC") on its Electronic Data Gathering, Analysis, and
            Retrieval Filer Management website a Form ID application, including
            any amendments and exhibits thereto, and any other related documents
            as may be necessary or appropriate, to obtain from the SEC access
            codes to permit filing on the SEC's EDGAR system, granting unto said
            attorneys-in-fact and agents full power and authority to do and
            perform each act and thing requisite and necessary to be done as
            required by any rule or regulation of the SEC and the EDGAR Filer
            Manual as fully and to all intents and purposes as the undersigned
            might or could do in person, hereby ratifying and confirming all
            that said attorneys-in-fact and agents  may lawfully do or cause to
            be done by virtue hereof; and

        2.  sign any and all SEC statements of beneficial ownership of
            securities of the undersigned relating to NOV Inc. (the "Company")
            on Schedule 13D as required under Section 13 and Forms 3, 4 and 5 as
            required under Section 16(a) of the Securities Exchange Act of 1934,
            as amended, and any amendments thereto, and to file the same with
            all exhibits thereto, and other documents in connection therewith,
            with the SEC, the Company, and any stock exchange on which any of
            the Company's securities are listed, granting unto said attorneys-
            in-fact and agents full power and authority to do and perform each
            act and thing requisite and necessary to be done under said Section
            13 and Section 16(a), as fully and to all intents and purposes as
            the undersigned might or could do in person, hereby ratifying and
            confirming all that said attorneys-in-fact and agents may lawfully
            do or cause to be done by virtue hereof.

        A copy of this power of attorney shall be filed with the SEC. The
authorization set forth above shall continue in full force and effect until the
undersigned revokes such authorization by written instructions to the attorney-
in-fact.

        The authority granted hereby shall in no event be deemed to impose or
create any duty on behalf of the attorneys-in-fact with respect to the
undersigned's obligations to file a Form ID, Schedule 13Ds and Forms 3, 4 and 5
with the SEC.


Dated: September 28, 2021

                                        By: /s/ Christy Novak
                                            ------------------------------------
                                            Name: Christy Lynn Novak